iBio
IBIO
#10251
Rank
S$74.88 M
Marketcap
S$1.51
Share price
0.85%
Change (1 day)
39.09%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): S-$0.99

According to iBio's latest financial reports the company's current EPS (TTM) is S-$0.96. In 2025 the company made an earnings per share (EPS) of S-$2.24 an increase over its 2024 EPS that were of S-$8.30.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.99-55.59%
2025S-$2.24-73.08%
2024S-$8.30-93.88%
2023S-$135.65-8.14%
2022S-$147.6792.67%
2021S-$76.65-80.33%
2020S-$389.62-35.11%
2019S-$600.40-38.96%
2018S-$983.64-6.1%
2017S-$1,04836.67%
2016S-$766.4733.33%
2015S-$574.8550%
2014S-$383.23-53.85%
2013S-$830.34-7.14%
2012S-$894.21-64.1%
2011S-$2,49177.27%
2010S-$1,405144.44%
2009S-$574.8512.93%
2008S-$509.0512.2%
2007S-$453.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.16-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S-$0.66-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$8.56 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.39 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA